Recent Updates
-
Rucaparib: A Powerful PARP Inhibitor for Cancer PatientsRucaparib is a potent PARP (Poly ADP-Ribose Polymerase) inhibitor that has revolutionized cancer treatment, particularly for patients with advanced ovarian, prostate, and other BRCA-mutated cancers. By inhibiting the PARP enzyme, Rucaparib prevents cancer cells from repairing their damaged DNA, leading to cell death and tumor reduction. This targeted mechanism enhances its effectiveness while...0 Comments 0 Shares 141 Views 0 ReviewsPlease log in to like, share and comment!
-
0 Comments 0 Shares 46 Views 0 Reviews
More Stories